1.Hashimoto's disease complicated with thyroid cancer: 54 cases.
Hongtao LI ; Guanghui REN ; Chao DONG ; Alibiyati AINI ; Binlin MA
Journal of Central South University(Medical Sciences) 2011;36(8):765-767
OBJECTIVE:
To investigate the clinical characteristics and surgical treatment of Hashimoto's disease complicated with thyroid cancer.
METHODS:
Clinical data of 54 patients with Hashimoto's disease complicated with thyroid cancer were retrospectively analyzed, including clinical characteristics, surgical treatment, and short-term effects.
RESULTS:
The rate of Hashimoto's disease complicated with thyroid cancer was 14.9%, 54 out of in 362 patients with Hashimoto's disease. All the 54 patients had surgical treatment in proper thyroid region, took euthyrox after the operation and had 6 month to 4 year followup. One patient had a local recurrence and 3 had lymph node metastasis in the neck, and these 4 patients had second operation on the thyroid gland. No death occurred.
CONCLUSION
Hashimoto's disease complicated with thyroid cancer has no typical symptoms.Combined examination of anti-thyroid antibodies test, color doppler imaging, CT detection, isotope scan and core/fine needle biopsy may provide accurate diagnosis. Proper surgical treatment is effective for Hashimoto's disease complicated with thyroid cancer.
Adult
;
Aged
;
Carcinoma, Papillary
;
complications
;
diagnosis
;
surgery
;
Female
;
Hashimoto Disease
;
complications
;
diagnosis
;
surgery
;
Humans
;
Male
;
Middle Aged
;
Retrospective Studies
;
Thyroid Neoplasms
;
complications
;
diagnosis
;
surgery
;
Young Adult
2.Diagnosis and surgical treatment of Hashimoto's thyroiditis complicated with papillary thyroid carcinoma (with 51 cases of clinical analysis).
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2010;24(6):257-260
OBJECTIVE:
To analyze the experience in diagnosis, treatment and prognosis of Hashimoto's thyroiditis (HT) with coexistent thyroid papillary carcinoma(PTC).
METHOD:
Fifty-one cases of concomitant HT and PTC treated from February 2001 to 2008 October were retrospectively reviewed.
RESULT:
Twenty-eight cases of patients underwent thyroid-associated antibody test,with 5 cases TG-Ab elevated and 15 cases TPO-Ab elevated. All 51 cases were detected with thyroid solid mass on B ultrasonography test,and twenty-two cases had evidence of calcification on B ultrasound preoperatively (43.14%), five cases were suspicious of malignancy. Thyroid fine needle aspiration cytology prompted 2 cases of suspected cancer, 1 case highly suspected malignant. All patients underwent surgical treatment. In a follow-up for 8-100 months, 2 people were lost to follow-up,and the others had no recurrence or metastasis.
CONCLUSION
HT associated with thyroid nodules should be vigilant against malignant tendency. Preoperative combined thyroglobulin antibody (TG-Ab), antithyroid peroxidase antibody (TPO-Ab), imaging examination and fine needle aspiration cytology, contribute to the diagnosis of PTC combined HT. Surgical procedure of combined HT with PTC is the effective treatment, and the principles of its surgical treatment may be in accordance with the principle of PTC. Surgical treatment is effective with good prognosis.
Adolescent
;
Adult
;
Aged
;
Carcinoma
;
Carcinoma, Papillary
;
Female
;
Hashimoto Disease
;
complications
;
diagnosis
;
surgery
;
Humans
;
Male
;
Middle Aged
;
Prognosis
;
Retrospective Studies
;
Thyroid Cancer, Papillary
;
Thyroid Neoplasms
;
complications
;
diagnosis
;
surgery
;
Young Adult
3.Xanthogranulomatous Pancreatitis Combined with Intraductal Papillary Mucinous Carcinoma In Situ.
Yo Na KIM ; Shin Young PARK ; Young Kon KIM ; Woo Sung MOON
Journal of Korean Medical Science 2010;25(12):1814-1817
Xanthogranulomatous lesion is a rare condition in which lipid-laden histiocytes are deposited at various locations in the body. Xanthogranulomatous pancreatitis (XGP) associated with an intraductal papillary mucinous tumor (IPMT) is extremely rare. In this study, we described a case of XGP associated with IPMT and include a review of the literature. A pancreatic cystic mass was detected in a 72-yr-old woman by abdominal computed tomography. Pylorus-preserving pancreaticoduodenectomy was performed and diagnosis of XGP combined with intraductal papillary mucinous carcinoma in situ was made. After 13 months of follow-up, the patient is in good health without any evidence of tumor recurrence. Although XGP associated with IPMT is rare, we suggest that such cases should be brought to the attention of clinical investigators, as it may produce clinical features that mimic pancreatic cancer.
Adenocarcinoma, Mucinous/*diagnosis/pathology/surgery
;
Aged
;
Carcinoma in Situ/*diagnosis/pathology/surgery
;
Carcinoma, Pancreatic Ductal/*diagnosis/pathology/surgery
;
Carcinoma, Papillary/*diagnosis/pathology/surgery
;
Diagnosis, Differential
;
Female
;
Granuloma/complications/*diagnosis
;
Humans
;
Magnetic Resonance Imaging
;
Pancreatic Neoplasms/*diagnosis/pathology/surgery
;
Pancreaticoduodenectomy
;
Pancreatitis/complications/*diagnosis
;
Tomography, X-Ray Computed
;
Xanthomatosis/complications/*diagnosis
4.A Case of Peutz-Jeghers Syndrome with Intraductal Papillary Mucinous Carcinoma of Pancreas.
Pyung Gohn GOH ; Hee Seok MOON ; Jae Kyu SUNG ; Hyun Yong JEONG ; Kyu Sang SONG
The Korean Journal of Gastroenterology 2010;55(1):73-77
Peutz-Jeghers syndrome (PJS), which is characterized by multiple hamartomatous polyps of the gastrointestinal tract and mucocutaneous pigmentation, is a rare autosomal dominant disease. This syndrome is often represented as a surgical emergency with complications of the polyps such as intussusception, small bowel obstruction, bleeding, and volvulus. In particular, many studies have reported that patients with this syndrome have a high risk of gastrointestinal or extragastrointestinal malignancy including gastric, duodenal, jejunal, ileal, and colonic carcinoma as well as malignancies involving other organs such as the gallbladder, biliary tract, pancreas, tonsils, breast, and reproductive system. However, there are few reported cases of an association of this syndrome with extraintestinal malignancy. In addition to that, there is no reported case of this syndrome with malignant tumor or intraductal papillary mucinous tumor of pancreas in Korea. We experienced a case of PJS accompanying intraductal papillary mucinous carcinoma of the pancreas, therefore we report this case with literatures reviewed.
Adenocarcinoma, Mucinous/*diagnosis/pathology/secondary
;
Carcinoma, Papillary/*diagnosis/pathology/secondary
;
Humans
;
Intussusception/surgery
;
Jejunum/surgery
;
Male
;
Middle Aged
;
Pancreatic Neoplasms/complications/*diagnosis/pathology
;
Peutz-Jeghers Syndrome/complications/*diagnosis
;
Tomography, X-Ray Computed
5.A Case of Peutz-Jeghers Syndrome with Intraductal Papillary Mucinous Carcinoma of Pancreas.
Pyung Gohn GOH ; Hee Seok MOON ; Jae Kyu SUNG ; Hyun Yong JEONG ; Kyu Sang SONG
The Korean Journal of Gastroenterology 2010;55(1):73-77
Peutz-Jeghers syndrome (PJS), which is characterized by multiple hamartomatous polyps of the gastrointestinal tract and mucocutaneous pigmentation, is a rare autosomal dominant disease. This syndrome is often represented as a surgical emergency with complications of the polyps such as intussusception, small bowel obstruction, bleeding, and volvulus. In particular, many studies have reported that patients with this syndrome have a high risk of gastrointestinal or extragastrointestinal malignancy including gastric, duodenal, jejunal, ileal, and colonic carcinoma as well as malignancies involving other organs such as the gallbladder, biliary tract, pancreas, tonsils, breast, and reproductive system. However, there are few reported cases of an association of this syndrome with extraintestinal malignancy. In addition to that, there is no reported case of this syndrome with malignant tumor or intraductal papillary mucinous tumor of pancreas in Korea. We experienced a case of PJS accompanying intraductal papillary mucinous carcinoma of the pancreas, therefore we report this case with literatures reviewed.
Adenocarcinoma, Mucinous/*diagnosis/pathology/secondary
;
Carcinoma, Papillary/*diagnosis/pathology/secondary
;
Humans
;
Intussusception/surgery
;
Jejunum/surgery
;
Male
;
Middle Aged
;
Pancreatic Neoplasms/complications/*diagnosis/pathology
;
Peutz-Jeghers Syndrome/complications/*diagnosis
;
Tomography, X-Ray Computed
6.Development of Thyroid-Associated Ophthalmopathy in Patients Who Underwent Total Thyroidectomy.
Sun Young JANG ; Ka Hyun LEE ; Jong Rok OH ; Bo Yeon KIM ; Jin Sook YOON
Yonsei Medical Journal 2015;56(5):1389-1394
PURPOSE: To report clinical characteristics of thyroid-associated ophthalmopathy (TAO) in patients who previously underwent total thyroidectomy for thyroid cancer or a benign mass of the thyroid. MATERIALS AND METHODS: Of the patients who were diagnosed with TAO from March 2008 to March 2012, we performed a retrospective chart review on those who had undergone total thyroidectomy for thyroid cancer or a benign mass of the thyroid before the occurrence of ophthalmopathy. RESULTS: Of the 206 patients diagnosed with TAO, seven (3.4%) met the inclusion criteria. The mean age of the subjects was 47.4 years, and all were female. Six patients were diagnosed with papillary thyroid cancer, and one was diagnosed with a benign mass. The duration between total thyroidectomy and onset of TAO ranged from 3-120 months (median 48 months). Ophthalmic manifestations varied among cases. Except for the patient who was diagnosed with a benign mass, all patients showed hyperthyroid status and were under Synthroid hormone treatment at the time of TAO development. Five of these six patients had positive levels of thyroid-stimulating hormone (TSH) receptor autoantibodies. CONCLUSION: TAO rarely develops after total thyroidectomy, and the mechanism of TAO occurrence is unclear. However, most patients showed abnormalities in thyroid function and TSH receptor autoantibodies.
Adult
;
Aged
;
Autoantibodies/blood
;
Carcinoma
;
Carcinoma, Papillary/immunology/surgery
;
Female
;
Graves Ophthalmopathy/*diagnosis/immunology
;
Humans
;
Male
;
Middle Aged
;
Postoperative Complications/etiology/immunology/pathology
;
Receptors, Thyrotropin
;
Retrospective Studies
;
Thyroid Neoplasms/complications/*surgery
;
Thyroidectomy/adverse effects/*methods
;
Thyrotropin/blood
;
Treatment Outcome
7.Dyshormonogenetic goiter: clinicopathologic study of four cases.
Xiao-yan CHANG ; Ying JIANG ; Di YANG ; Jie CHEN
Chinese Journal of Pathology 2007;36(1):39-42
OBJECTIVETo study the clinicopathologic features and differential diagnosis of dyshormonogenetic goiter.
METHODSThe clinical features, histopathologic findings and immunohistochemistry of four cases of dyshormonogenetic goiter were reviewed.
RESULTSAmongst the cases of dyshormonogenetic goiter studied, three were females and one male. The age of disease onset ranged from 6 to 12 years and the age at operation ranged from 13 to 28 years. Three patients presented with symptoms of hypothyroidism and one patient had normal thyroid function. On gross examination, the thyroid was multinodular and covered by fibrous capsule. Histologically, three patterns were observed. The predominant pattern was microfollicular/trabecular, with hyperplastic follicular cells associated with scanty colloid material. The second pattern was macrofollicular, the follicular cells were cuboid in shape, with inconspicuous mitotic figures. The third pattern was microcystic, with papillary component frequently seen. No normal intervening thyroid parenchyma was found. All the patients were on long-term thyroxine replacement therapy after operation and remained well.
CONCLUSIONSDyshormonogenetic goiter is considered as a form of thyroid hyperplasia due to enzymatic defects in hormone synthesis. The architectural polymorphism and cellular atypia may mimic thyroid neoplasms and cause difficulties in differential diagnosis.
Adolescent ; Adult ; Carcinoma, Papillary ; pathology ; Diagnosis, Differential ; Female ; Goiter ; complications ; pathology ; surgery ; Humans ; Hypothyroidism ; complications ; pathology ; surgery ; Male ; Thyroid Gland ; metabolism ; pathology ; surgery ; Thyroid Neoplasms ; pathology ; Thyroidectomy ; Thyroiditis ; pathology ; Thyrotropin ; metabolism ; Young Adult
8.Coexistence of Chronic Lymphocytic Thyroiditis with Papillary Thyroid Carcinoma: Clinical Manifestation and Prognostic Outcome.
Jun Soo JEONG ; Hyun Ki KIM ; Cho Rok LEE ; Seulkee PARK ; Jae Hyun PARK ; Sang Wook KANG ; Jong Ju JEONG ; Kee Hyun NAM ; Woong Youn CHUNG ; Cheong Soo PARK
Journal of Korean Medical Science 2012;27(8):883-889
The study aimed to identify the clinical characteristics of coexisting chronic lymphocytic thyroiditis (CLT) in papillary thyroid carcinoma (PTC) and to evaluate the influence on prognosis. A total of 1,357 patients who underwent thyroid surgery for PTC were included. The clinicopathological characteristics were identified. Patients who underwent total thyroidectomy (n = 597) were studied to evaluate the influence of coexistent CLT on prognosis. Among the total 1,357 patients, 359 (26.5%) had coexistent CLT. In the CLT group, the prevalence of females was higher than in the control group without CLT (P < 0.001). Mean tumor size and mean age in the patients with CLT were smaller than without CLT (P = 0.040, P = 0.047, respectively). Extrathyroidal extension in the patients with CLT was significantly lower than without CLT (P = 0.016). Among the subset of 597 patients, disease-free survival rate in the patients with CLT was significantly higher than without CLT (P = 0.042). However, the multivariate analysis did not reveal a negative association between CLT coexistence and recurrence. Patients with CLT display a greater female preponderance, smaller size, younger and lower extrathyroidal extension. CLT is not a significant independent negative predictive factor for recurrence, although presence of CLT indicates a reduced risk of recurrence.
Adult
;
Carcinoma/complications/*diagnosis/surgery
;
Carcinoma, Papillary/complications/*diagnosis/surgery
;
Disease-Free Survival
;
Female
;
Follow-Up Studies
;
Hashimoto Disease/complications/mortality/*pathology
;
Humans
;
Lymphatic Metastasis
;
Male
;
Middle Aged
;
Neoplasm Staging
;
Odds Ratio
;
Predictive Value of Tests
;
Prognosis
;
Recurrence
;
Sex Factors
;
Survival Rate
;
Thyroid Neoplasms/complications/*diagnosis/surgery
;
Thyroidectomy
9.Clear cell papillary cystadenoma of left mesosalpinx associated with von Hippel-Lindau disease: report of a case.
Xiang-lei HE ; Chun-nian WANG ; Jian-min ZHANG
Chinese Journal of Pathology 2009;38(5):349-350
Adenocarcinoma, Clear Cell
;
complications
;
metabolism
;
pathology
;
surgery
;
Adenoma
;
pathology
;
Adnexal Diseases
;
pathology
;
Adult
;
Carcinoma, Renal Cell
;
pathology
;
secondary
;
Cystadenoma, Papillary
;
complications
;
metabolism
;
pathology
;
surgery
;
Diagnosis, Differential
;
Fallopian Tube Neoplasms
;
complications
;
metabolism
;
pathology
;
surgery
;
Female
;
Follow-Up Studies
;
Humans
;
Keratin-7
;
metabolism
;
Kidney Neoplasms
;
pathology
;
secondary
;
Mucin-1
;
metabolism
;
von Hippel-Lindau Disease
;
complications
;
metabolism
;
pathology
;
surgery
10.Clinicopathologic features of parathyroid carcinoma: a study of 11 cases with review of literature.
Chinese Journal of Pathology 2014;43(5):296-300
OBJECTIVETo study the clinicopathologic characteristics of parathyroid carcinoma (PTC).
METHODSEleven cases of PTC encountered during the period from 1994 to 2012 were enrolled into the study. Forty cases of parathyroid adenoma (PA) were also retrieved for comparison. The clinical manifestations, laboratory results and pathologic features were analyzed, with literature review.
RESULTSThe main clinical manifestations of PTC included neck mass (11/11), hypercalcemia (11/11) and hyperparathyroidism (11/11). Most patients also had osteoporosis (10/11). In contrast, PA often manifested as hypercalcemia (40/40) and hyperparathyroidism (40/40). Histologic examination of PTC showed that the tumor cells contained clear to eosinophilic cytoplasm and separated by dense bands of fibrosis. The tumor mass was surrounded by thick fibrous capsule. Foci of capsular invasion and vascular permeation were identified at the tumor periphery in all cases. Cellular atypia was not conspicuous but mitotic figures and coagulative necrosis were easily identified. On the other hand, PA were composed of tumor cells with clear to eosinophilic cytoplasm, forming glands, trabeculae or nests. Most of them (35/40) had intact fibrous capsule. Mitotic figures were rarely encountered and tumor necrosis was absent. Immunohistochemical study showed that the tumor cells in PTC were positive for CK19 (11/11), chromogranin A (9/11), synaptophysin (7/11) and parathyroid hormone (11/11). They were negative for thyroglobulin, TTF-1 and calcitonin. The Ki-67 index was less than 10% (range = 2% to 9%). In contrast, the tumor cells in PA were positive (40/40) for CK19, chromogranin A, synaptophysin and parathyroid hormone. They were negative for thyroglobulin, TTF-1 and calcitonin. The Ki-67 index was less than 3%. Follow up-data were available in 9 cases of PTC (duration of follow up = 11 months to 224 months) and 7 of the patients were still alive. Follow up of all PA cases showed no evidence of recurrence.
CONCLUSIONSPTC is a rare malignant endocrine tumor presenting as neck mass. Histologic features suggestive of malignant behavior include presence of coagulative tumor necrosis and capsular/vascular invasion. It needs to be distinguished from other entities such as parathyroid adenoma, papillary thyroid carcinoma and medullary thyroid carcinoma.
Adenoma ; metabolism ; pathology ; Adult ; Carcinoma ; metabolism ; pathology ; Carcinoma, Neuroendocrine ; Carcinoma, Papillary ; Chromogranin A ; metabolism ; Diagnosis, Differential ; Female ; Follow-Up Studies ; Humans ; Hypercalcemia ; etiology ; Hyperparathyroidism ; etiology ; Immunohistochemistry ; Keratin-19 ; metabolism ; Male ; Middle Aged ; Osteoporosis ; etiology ; Parathyroid Hormone ; metabolism ; Parathyroid Neoplasms ; complications ; metabolism ; pathology ; surgery ; Synaptophysin ; metabolism ; Thyroid Neoplasms ; metabolism ; pathology